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Abstract
The gastric epithelium consists of different types of cells, which are involved in gastric
homeostasis by balancing cell proliferation and differentiation. This process involves
several signaling molecules such as growth factors, hormones and vitamins. Vitamin
D3 (VD3) is engaged in several biological activities. It plays a role in cell
differentiation, cell proliferation, immune response and also regulates calcium
homeostasis. The biological activities of VD3 are mediated by vitamin D receptor
(VDR). Target tissues of VD3 in the gastrointestinal tract were identified earlier in
intestine, colon and gastric cancer tissues; however, the normal expression of VDR in
stomach is poorly studied. So, the main objectives of this thesis are: 1) to investigate
the normal expression, distribution and cellular localization of VDR in gastric
epithelium and 2) to study possible role of VDR and VD3 in maintaining gastric stem
cells proliferation and differentiation by establishing and analyzing mouse model
deficient in VD3. Polymerase chain reaction (PCR) analysis showed that VDR as well
as enzymes involved in VD3 metabolism are expressed in the different region of
normal mouse stomach. Co-immunostaining analysis showed specific expression of
VDR in the acid secreting parietal cells and the different mucus secreting cells. The
results suggested that parietal cells and mucous cells are targets for VD3 signaling. To
examine the role of VD3 on gastric homeostasis, wild type mice were put on VD3
deficient diet for 3 months. Using Real-Time Polymerase Chain Reaction (Real-Time
PCR), stomachs of mice deficient of vitamin D showed significant decrease in
expression of parietal cell specific genes (HKα and HKβ) and increase gastrin gene
expression. Moreover, quantification for cells in the S-phase of the cell cycle showed
significant increase in their number in vitamin D deficient mice compared to controls.
Gene expression analysis of VDR signaling genes showed significant decrease in
PTHLH, but not other target genes like TRPV6 and p21. This work will add value to
the field of stomach biology by providing better understanding of how VD3 and VDR
are involved in maintaining gastric epithelial homeostasis and how that is related to
some stomach conditions such as low gastric acidity and gastric cancer.

Keywords: Vitamin D3, VDR, Gastric epithelium, Stem cell, Proliferation,
Differentiation.
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)Title and Abstract (in Arabic

دور مستقبالت فيتامين د في توازن الخاليا المعدية
الملخص

تتكون بطانة المعدة من عدة أنواع من الخاليا التي تساهم في الحفاظ على توازنها عن طريق
الموازنة بين تزايد أعداد هذه الخاليا و بين تمايزها الى خاليا أخرى متخصصة .تساهم في هذه
العملية العديد من الجزيئات :مثل عوامل النمو و الهرمونات و الفيتامينات .يلعب فيتامين د )(VD3
دورا في تمايز الخاليا وتتزايدها
دورا ً مهما ً في العديد من االنشطة البيولوجية ،حيث يلعب
ً
ضا توازن الكالسيوم في الجسم .يتوسط هذه النشاطات البيولوجية
واالستجابة المناعية وينظم أي ً
لفيتامين د مستقبالتها الخاصة والتي تعرف بمستقبالت فيتامين د ) . (VDRمن خالل االبحاث
السابقة تم تحديد األنسجة المستهدفة من فيتامين د في الجهاز الهضمي والتي تتمثل باألمعاء و
القولون واالنسجة السرطانية في المعدة ،ولكن دور هذه المستقبالت في المعدة لم يتم دراسته بشكل
كافي .تتمحور األهداف الرئيسة لهذه األطروحة حول )1 :التحقق من تواجد مستقبالت فيتامين د
في أنسجة وخاليا المعدة وأيضا  )2دراسة دور مستقبالت فيتامين د في الحفاظ على توازن الخاليا
الجذعية للمعدة ،من حيث تزايد أعدادها وتمايزها عن طريق تطبيق بعض التقنيات مثل صبغ
أنسجة المعدة بأنواع خاصة من األجسام المضادة ( )Immunohistochemistryو دراسة معدل
تغير بعض الجينات ( .)Real-Time PCRمن خالل استخدام نموذج لفئران تعاني من نقص
فيتامين د أظهرت نتائجنا أن مستقبالت فيتامين د باإلضافة إلى اإلنزيمات المشاركة في عملية
تكوين فيتامين د تتواجد في أجزاء المختلفه من المعدة .كما أظهرنا انخفاض كبير في تواجد
الحمض النووي الرايبوزي من النوع ( )mRNAللجينات ( )HKβو ( )HKαو ارتفاع الحمض
النووي الرايبوزي للجين ( )gastrinفي الفئران التي تعاني من نقص فيتامين د .وعالوة على
ذلك  ،أظهرت النتائج التي توصلنا إليها زيادة كبيرة في عدد الخاليا الجذعية و أيضا تراجع
النسبيي لبعض الجينات المستهدفة من فيتامين د مثل (  )PTHLH ،p21 ،TRPV6فقط في
الفئران التي تعاني من نقص في فيتامين د .سيضيف هذا العمل قيمة إلى حقل األبحاث من خالل
توضيح كيفية مشاركة فيتامين د و مستقبالت فيتامين د في الحفاظ على توازن الخاليا الجذعية
في المعدة وكيف يرتبط ذلك ببعض الحاالت الصحية مثل انخفاض حموضة المعدة وسرطان
المعدة.

ix

مفاهيم البحث الرئيسية :فيتامين د ،مستقبالت فيتامين د ،خاليا بطانة المعدة ،الخاليا الجذعية،
تزايد الخاليا ،تمايز الخاليا.
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Chapter 1: Introduction
1.1 Overview
Vitamins are organic compounds with several metabolic functions, they are
distinct from minerals, amino acids and fatty acids [1]. Vitamins are nutritional factors,
naturally present in the diet, required in small quantities and essential for the body to
perform its ordinary physiological functions such as growth, reproduction and
maintenance. It is remarkable to realize that not all vitamins are found in diet, some of
them need further activation in our body to be converted into their functional form.
There are various types of vitamins such as vitamin A, vitamin B1, vitamin B2, vitamin
B6, vitamin B12, vitamin C, vitamin D, vitamin E, vitamin K, Niacin, Biotin, Folic
acid and Pantothenic acid [2].
Some of these vitamins such as biotin and vitamin B6 act as coenzymes for
carboxylations, fatty acid metabolism or amino acid metabolism [2]. Moreover,
vitamin A is essential for the growth and eye vision [3].
The classical effect of vitamin D is very much connected to bone structure and
regulation of calcium homeostasis [4]. Nevertheless, vitamin D is also involved in
several cellular processes, such as cell differentiation [5] and proliferation [6].
Moreover, vitamin D contributes significantly to many physiological functions like
pancreatic secretion of insulin [7], in cardiovascular system [8] as well as immune
response [9].
This introductory chapter is shedding light on vitamin D3 and vitamin D
receptor. It begins with brief historical overview of vitamin D, followed by description
of its structure, metabolism process as well as how its function is meditated by vitamin
D receptor. The role of the ligand and its receptor in health and disease will be
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illustrated as well. Furthermore, throughout the chapter the expression and the function
of vitamin D receptor in gastrointestinal tract and other tissues will be demonstrated.
1.2 Vitamin D
The early discovery of vitamin D started with a series of experiments aimed to
study rickets disease; which is defective calcification of bones, in different models. A
classical experiment conducted by Edward Mellanby involving two months old
puppies which were provided with specific diet known to produce rickets. Another
group of puppies was fed the same diet in addition to other kinds of food such as meat,
malt extract, butter, yeast extract and cod liver oil. The puppies were kept indoor
inadvertently. The observation was that the group of puppies fed diet with cod liver oil
or butter didn’t develop rickets at all Rickets was diagnosed by using X-ray. The
conclusion of this work was that the presence of certain fat-soluble accessory factors
such as cod liver oil or butter in the diet can prevent rickets disease [10].
McCollum also discovered earlier that some fats contain dietary substances
which are involved in the growth process [3]. In 1919, he found that cod liver oil
contains substance which could prevent rickets and named it vitamin D [11].
Other than the supplementary factors in the diet, Harriette Chick and her
colleagues [12] as well as other researchers [13] demonstrated the effect of sunlight in
curing rickets in children. So the dominated idea at that time was that some dietary
factors such as cod liver oil and sunlight can attribute in preventing and curing rickets.
Furthermore, to investigate whether the fatty dietary factors from plants represented
by phytosterol can have anti-rachitic effect just like animal fat (i.e. cod liver oil) as
noticed earlier, Alfred Hess and his team prepared rickets producing diet along with
phytosterol extracted from cottonseeds. A group of rats was fed an UV-irradiated
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extract of this diet, while another group was fed non-irradiated extract. The same
experiment was repeated by using cholesterol extracted from brain tissue. They noticed
that the group of rats which had irradiated phytosterol or cholesterol didn’t produce
rickets disease unlike the other group, concluding that the irradiation of the fatty
substance is a critical step for the rickets prevention. Furthermore, they hypothesized
that cholesterol which is present in our skin cells can be converted to the active form
of cholesterol by UV irradiation, and then circulated in the body in order to prevent
rickets [14]. Thereafter, it was discovered that the precursor molecule is not
cholesterol, but in fact another impurity found within the cholesterol which acts as
anti-rickets factor and was named as provitamin [15]. Moreover, the provitamin should
be irradiated by UV light to be converted to vitamin D [16].
1.2.1 Vitamin D2 and Vitamin D3
Vitamin D is widely described as hormone since it is derived from pro-steroid.
There are two different forms of vitamin D: Vitamin D 2 , Ergocalciferol [17] and
Vitamin D3 , Cholecalciferol [18]. Ergocalciferol is a plant based form of vitamin D,
it is derived from the provitamin ergosterol which is converted into ergocalciferol by
UV irradiation [17].
On the other hand, Cholecalciferol is produced in the epidermis of animals and
humans by the photolysis of the sterol precursor; 7-dehydrocholesterol [18].
Ergocalciferol and Cholecalciferol have slight differences in their structure. The
absence of double bond between C22 and C23 and absence of methyl group at C24 in
Cholecalciferol lead to a distinct side chain for each of vitamin D forms (Figure 1.1).
However, both can be converted to 25-hydroxyvitamin D [18], [19].
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Figure 1.1: Molecular structure of the two forms of vitamin D.
(A) Ergocalciferol (B) Cholecalciferol. Ergocalciferol is characterized by having
double bond between C22 and C23 and methyl group at C24 [18].

1.2.2 Vitamin D Metabolism
Ergocalciferol and Cholecalciferol can be obtained from dietary sources,
however, the main source of Cholecalciferol is the skin. The provitamin molecule; 7dehydrocholesterol is naturally present in animal cells, specifically in the skin, and
works as precursor for Cholecalciferol. After the exposure to sunlight, ultra-violet
radiation B (UV-B) converts 7-dehydrocholesterol to previtamin that has unstable
structure and consequently isomerizes to form Cholecalciferol in the plasma
membrane of the skin cells. As Cholecalciferol leaves the plasma membrane to the
extracellular fluid space, it binds to Vitamin D Binding Protein (DBP) in the blood
stream for translocation [20]. Illustration of vitamin D activation is demonstrated in
(Figure 1.2).
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Figure 1.2: Vitamin D3 synthesis pathway.
UVB radiation converts 7-dehydrocholesterol to Cholecalciferol through
photochemical reaction. CYP2R1 and CYP27A1 enzymes synthesize 25hydroxyvitamin D3 (25(OH)D3) from Cholecalciferol in liver. 25-hydroxyvitamin D3
(25(OH)D3) is translocated to kidney to be further synthesized to the active form of
vitamin D3; 1α,25-dihydroxyvitamin D3 (1α,25(OH)2D3) by the enzyme CYP27B1.

Thereafter, Cholecalciferol is translocated to the liver where the enzymes 25hydroxylase

(CYP2R1)

and

sterol

27-hydroxylase

(CYP27A1)

convert

Cholecalciferol to 25-hydroxyvitamin D3 (25(OH)D3). As 25(OH)D3 is synthesized, it
is transported mainly to the kidney via DBP where it is further hydroxylated to produce
the biologically active form of VD3; 1α,25-dihydroxyvitamin D3 (1α,25(OH)2D3) by
the enzyme 1α-hydroxylase (CYP27B1); an enzyme mainly expressed in the kidney.
Then 1α,25(OH)2D3 travels to vitamin D target tissues such as bone and intestine to
perform its biological functions which are mediated by Vitamin D Receptor (VDR)
(Figure 1.2) [21]. 1α,25(OH)2D3 is lipophilic steroid hormone with long and flexible
structure [22].
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As demonstrated earlier, there are distinct key proteins involved in vitamin D
metabolism, these proteins include some cytochrome P450 enzymes (CYPs) as well
as DBP. Cytochrome P450 2R1 enzyme (CYP2R1), also known as vitamin D 25hydroxylase is encoded by the gene CYP2R1, this microsomal hepatic enzyme has
vitamin D 25-hydroxylase activity and it is the major contributor to 25(OH)D 3
synthesis [23], [24]. Zhu et al showed that more than 50% decline in serum 25(OH)D3
level and steady level of serum 1α,25(OH)2D3 in CYP2R1-/- mice comparing to wild
type. These knockout mice had no other serious health problems [24]. While in human,
mutation in CYP2R1 gene developed symptoms of vitamin D-dependent rickets in
children as illustrated in a clinical study [25].
Cytochrome P450 27A1 enzyme (CYP27A1) which commonly known as
sterol 27-hydroxylase is mitochondrial hepatic enzyme primarily responsible for bile
acid formation [26]. Additionally, this enzyme also has the ability to stimulate the
conversion of Cholecalciferol to 25(OH)D3 by hydroxylation [27]. In a previous study,
CYP27A1-/- mice experienced disruption in bile acid formation process and normal
vitamin D metabolites level [28]. Suggesting that CYP27A1 enzyme might be a minor
contributor in 25(OH)D3 formation.
Concluding, CYP2R1 and CYP27A1 which has different hepatic intracellular
localization are engaged in the enzymatic hydroxylation of Cholecalciferol to produce
25(OH)D3 in liver.
1α-hydroxylase (CYP27B1) is another enzyme from Cytochrome P450 superfamily, expressed in the proximal tubules of kidney, interestingly CYP27B1 is the sole
enzyme responsible for synthesizing 1α,25(OH)2D3 [21]. On the other hand, the
activity of CYP27B1 can be suppressed by serum 1α,25(OH)2D3 [29] as well as high
calcium levels in blood [30].
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Interestingly, 1α,25(OH)2D3 and 25(OH)D3 degradation is initiated by
Cytochrome P450 24 A1 enzyme (CYP24A1); 24-hydroxylase when necessary [31].
This enzyme is responsible for the catabolism of vitamin D, as it is capable of C24 or
C23 site hydroxylation. One of the final products of 1α,25(OH) 2D3 catabolism is
calcitroic acid; as a result of C24 hydroxylation [32].
Several studies showed that the expression of these enzymes is not specific for
the liver and kidney. In vitro studies illustrated that CYP27B1 is expressed in HaCaT
keratinocytes [33], macrophages [34] as well as bone [35]. While CYP2R1, CYP24A1
and CYP27B1 are expressed in placenta [36].
Another important protein in vitamin D metabolism and action is DBP. DBP
is from Group specific component proteins, this plasma protein has the ability to bind
to vitamin D and its metabolites serving in transporting them between tissues through
blood stream [37].

Table 1.1: Molecules involved in vitamin D3 synthesis
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1.3 Vitamin D Receptor
The biological activities and functions of 1α,25(OH)2D3 are mediated by VDR.
VDR is a member of nuclear receptors family; member 1 from nuclear receptor
subfamily 1, group I [38]. The function of VDR is highly correlated with its structure
and molecular nature. VDR has two conserved binding domains, Ligand Binding
Domain (LBD) and DNA Binding Domain (DBD) [39].
LBD represents the site where 1α,25(OH)2D3 or its analogs can bind,
heterodimerization with Retinoid X Receptor (RXR) occur and VDR-mediated
transcription activation take place throughout ligand-dependent transactivation
Function domain (AF-2). Whereas DBD is involved in the process of target genes
activation through the direct binding to the DNA via two zinc fingers [39], [40]. In
addition to these conserved domains, there are ligand-independent transactivation
function domain (AF-1) and Hinge domain which allow flexible rotation for the
receptor [40] (Figure 1.3).

Figure 1.3: Graphic representation of VDR structure.
AF-1 is toward N terminus site. DBD contains two zinc fingers which allow proper
binding to target genes. Hinge Domain provide rotational flexibility of VDR. ligands
and RXR bind to LBD, while coactivators interaction take place at AF-2 site.

Interestingly, VDR-LBD has two overlapping pockets; Genetic Pocket (GP)
(which is responsible of genetic responses when VDR acts as transcription factor), and
Alternative Pocket (AP) (which is involved in rapid responses [41] such as chloride
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channel regulation [42] and rapid intestinal calcium absorption) [43]. The activation
of VDR results from binding of 1α,25(OH) 2D3 to either pockets [44].
1.3.1 Mechanism of Action
Throughout this thesis, the active form of VD3 will be stated as 1α,25(OH)2D3.
VDR serves as ligand-dependent transcription factor when 1α,25(OH)2D3 binds to the
GP, leading to an interaction between the complex 1α,25(OH)2D3 and VDR with
another receptor know as Retinoid X Receptor (RXR). That interaction drives to
1α,25(OH)2D3-VDR-RXR heterodimer formation. The heterodimerized complex
travels to the nucleus where it recognizes and binds to Vitamin D Response Elements
(VDREs) located in the promoter of vitamin D direct target genes. As a result, the
activated VDR induces coactivators or corepressors to regulate the transcription of the
target genes directly (Figure 1.4). The transcription of these genes leads to the
production of proteins responsible for mediating the genetic functions of VDR
[44],[45]. VDREs is made up of two half-sites of similar, but not identical six
nucleotides separated by three nucleotides spacer [46].
VDR is also considered plasma membrane receptor, since it is associated with
the plasma membrane caveolae initiating rapid response (non-genetic mechanism). As
soon as the ligand binds to the AP, a rapid signal transduction pathways will be
activated such as rapid absorption of Ca2+ [44].
The ability of one ligand to induce two different responses when binding to a
single receptor is centered around the capability of 1α,25(OH)2D3 to undergo
conformational changes due to its flexible structure [47].
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1.3.2 Vitamin D Target Genes
The biological responses toward VD3 are mediated by VDR. 1α,25(OH)2D3
regulates transcription of several genes through VDRE on the promoter of these target
genes. Example of these target genes is Transient Receptor Potential Vanilloid member
6 (TRPV6), which is Ca2+ channel that plays a role in Ca2+ uptake in GI tract [48].
Chow et al. illustrated that capsaicin can induce apoptosis in gastric cancer cells
through TRPV6 mediated mechanism [49]. Parathyroid Hormone Like Hormone
(PTHLH) is another gene which is transcriptionally regulated by 1α,25(OH)2D3 [50].
PTHLH is involved in chondrocyte cells differentiation and proliferation and bone
resorption [51].
Moreover, Cyclin-Dependent Kinases Inhibitor (p21); a tumor suppressor that
cause cell cycle arrest is regulated by 1,25(OH)2D3 [52]. 1,25(OH)2D3 has
antiproliferative activities by modulating the expression of p21 via VDREs and further
having cell cycle regulatory effect [53].
Cathelicidin Antimicrobial Peptide (CAMP) gene is another vitamin D target
gene with VDREs [54]. These small peptides are stored in granules produced by
neutrophils in the skin and other tissues. They play an essential role in immune
response against viral and bacterial infection [55].
Moreover, cytochrome P450 3A4 (CYP3A4) is a gene expressed in liver as well
as intestine, directly regulated by vitamin D through VDREs [56]. CYP3A4 is mainly
involved in breaking down the toxic agent; secondary bile acid Lithocolic Acid (LCA).
This detoxification role of CYP3A4 is modulated by pregnane X receptor and nuclear
xenobiotic [57]. Furthermore, 1,25(OH)2D3 is a potent and direct inducer of RANKL
gene expression in osteoblastic cells [58]. The heterodimer VDR and act one RANKL
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promoter initiated osteoclast differentiation supporting its survival, and consequently
enhancing bone resorption [58].

13
Table 1.2: Some vitamin D3 target genes
Target Gene

Function

Reference

PTHLH

Parathyroid

Hormone Involved in stimulating bone [59]
resorption.
Induce
Like Hormone
myorelaxant effects in smooth
muscles of different organs.

TRPV6

Transient Receptor
Potential Vanilloid
member 6

Highly Ca2+ selective channel
protein that plays major role
in Ca2+ uptake in kidney and
gastrointestinal tract.

p21

Cyclin-Dependent

Tumor suppressor, that cause [60]
cell cycle arrest, by inhibiting
the cells to enter S phase.

Kinases Inhibitor
CAMP

Cathelicidin
Antimicrobial Peptide

Peptide agent
protective [55]
against microbial infections,
produced by neutrophils in
skin, aquamouse epithelial on
mouth, vagina and other
tissues.

CYP3A4

Cytochrome P450 3A4

RANKL

Receptor Activator of Essential for bone resorption.
Nuclear factor Kappa-Β
Ligand

[48]

Detoxification, by breaking [56]
down the hepatotoxic acid;
Lithocholic Acid.

[58]
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Figure 1.4: VDR genetic and non-genetic mechanisms.
For the genetic action, the ligand 1α,25(OH)2D3 binds to VDR, then the complex
interact with RXR leading to form heterodimer. VD3-VDR-RXR heterodimer travel to
the nucleus where it recognizes VDREs of the target gene and binds there inducing
coactivators or corepressors to regulate the transcription. For the non-genetic action,
1α,25(OH)2D3 binds to VDR which is associated with the plasma membrane caveolae
inducing rapidly response (Modified from [61]).
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1.4 Vitamin D and VDR in Health and Disease
It is well known that vitamin D plays a major role in maintaining calcium
homeostasis and bone health. In addition, researchers were very much interested to
study the non-skeletal actions of vitamin D, showing evidence that vitamin D status
and VDR are associated with multiple biological responses such as cell proliferation
[6], differentiation [62]. Vitamin D is also important for in the nervous system,
immune system [62] and cardiovascular system [63].
1.4.1 Calcium Homeostasis
The classical action of vitamin D is to maintain calcium (Ca2+) and phosphorus
(P) serum levels and bone mineralization. Once serum Ca2+ level decreases,
Parathyroid Hormone (PTH) is released acting on kidney to decrease loss of Ca 2+ in
urine. Moreover, PTH acts on stimulating bones to mobilize Ca 2+ from it and send it
directly to the blood. In addition to that, 1α,25(OH)2D3 can directly bind to VDR on
intestine leading to Ca2+ and P uptake. Finally these actions return Ca2+ to its normal
level [4].
1.4.2 Cell Differentiation
Far beyond the classical action, vitamin D can induce cell differentiation.
Wang et al showed that 1α,25(OH)2D3 has the ability to induce differentiation of
monocyte of human myeloid cells in HL60 cells. 1α,25(OH) 2D3 increased the
expression of Kinase Suppressor Of Ras 1 (KSR-1) gene which has VDREs,
stimulating monocytic differentiation [62].
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1.4.3 Cancer
Studies with system models of lung cancer [64], prostate cancer [65], breast
cancer [66] as well as hyperplasia of parathyroid gland [6] showed that 1α,25(OH)2D3
has anticancer effects by down-regulating the hyper-proliferative cells and promoting
apoptosis. Additionally, patients with pancreatic ductal adenocarcinoma showed
upregulation of CYP24A1 mRNA in malignant tissues comparing to nonmalignant
tissues of the pancreas. As a result, reducing the antiproliferative effect of
1α,25(OH)2D3 in malignant tissues [67].
1.4.4 Nervous System
Knowing that VDR is expressed in neurons [68], [69], [70], recent studies
suggested that some neurodegenerative diseases such as Alzheimer, Parkinson and
multiple sclerosis diseases are linked to Vitamin D deficiency [71]. These
neurodegenerative diseases are characterized by increased Ca2+ signaling [71]; and
since vitamin D controls the expression of Ca2+ regulating proteins [72], progress of
these diseases might be expected when there is low vitamin D in the body.
1.4.5 Cardiovascular System
Some studies demonstrated that low vitamin D levels due to insufficient UV
light intensity and dysregulation of the reactive oxygen species and Ca2+ signaling may
contribute to the pathogenesis of some cardiovascular diseases such as hypertension,
cardiac hypertrophy, congestive heart failure and atrial arrhythmias [63], [71].
1.4.6 Depression
In psychiatric conditions, vitamin D deficiency or insufficiency has been
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studied in depression cases. Milaneschi et al Showed association between 25(OH)D
serum level and depression in a study which involved group of individuals (1,102 with
current depressive disorders, 790 with previous depressive disorders, 495 control)
aged 18-65 years. The investigation showed lower 25(OH)D serum level among the
individuals with current depressive disorders as compared with the other groups [73].
1.4.7 Hair Loss
Moreover, studies in animals and human reported that vitamin D is linked to
hair loss. Xie et al demonstrated that lack of VDR affected hair growth by inhibiting
keratinocyte differentiation; consequently, preventing keratin lament bundles
formation in VDR knockout mouse. The phenotypes included expansion of hair
follicle with dermal cysts formation causing complete alopecia with time [74].
Furthermore, a study done on 80 females age between 18 to 45 years old with
hair loss disease; female pattern hair loss (FPHL) or chronic telogen effluvium (TE),
showed that vitamin D2 serum level was significantly lower in these females compared
to control group [75].
1.4.8 VDR Polymorphysims
In human, alterations in DNA sequence of VDR gene can cause major defects
in the gene activities. Point mutation in VDR gene has been linked to heredity vitamin
D-resistant rickets which is famous with insensitivity to 1α,25(OH) 2D3 by the target
tissues [76].
Diabetes Mellitus which is an endocrine-chronic disease has been also linked
to VDR polymorhysims. Early studies showed that in pancreas, insulin producing β
cells are expressing VDR [77]. Interestingly, it was found that insulin secretion reduced
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in VDR mutant mice [78] concluding that VDR plays a role in insulin secretion
process.
Moreover, an epidemiological study demonstrated an association between low
vitamin D level and decreased insulin sensitivity in healthy group with specific VDR
polymorphysim [79]. Another study had linked type 1 diabetes mellitus and BsmIVDR polymorphysim among diabetic Taiwanese population [80].
Furthermore, it was described that VDR polymorphisms has been associated
with secondary hyperparathyroidism in chronic renal failure, some cancers such as
breast and colon as well as some autoimmune diseases [81].
1.5 VDR in Gastrointestinal Tract
Target tissues of vitamin D throughout the gastrointestinal tract (GI tract) were
identified earlier in different animal models [82]. Animals injected with radiolabeled
1α,25(OH)2D3 followed by microscopic autoradiography examination showed many
ligand binding sites in the small intestine, stomach and colon [82].
VDR expression was reported in several tissues along the GI tract of normal
human and animals [83]. Using in situ hybridization and immunohistochemistry, small
intestine showed abundant distribution of VDR from duodenum to ileum. Moreover,
VDR expression was observed in normal colonic epithelial cells [84]. In stomach,
isthmus region in corpus and scattered cells in pyloric antrum were identified as target
tissues of 3H-1α,25(OH)2D3 [82] Columnar mucosa as well as Submucosal glands and
ducts of the human gastroesophageal junction showed positive immunofluorescence
to VDR [85].
Stating about cancerous tissue, VDR was poorly expressed in malignant gastric
tissue [86] and Barrett’s esophagus [85] when compared to normal tissues, suggesting
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that loss of VDR activity is associated with malignancy. Interestingly, the nonmalignant gastric tissues, premalignant gastric tissue and malignant gastric tissue were
expressing VDR in different levels. For example, the moderately differentiated
premalignant gastric tissues highly expressed VDR comparing to the poorly
differentiated premalignant gastric tissue [86], [85].
Therefore, being aware of the normal distribution of VDR in normal gastric
tissue might assist in diagnosing and assessing gastric cancer.
1.6 Mouse Gastric Epithelium
In human, the stomach is divided anatomically into three main parts, Fundus,
Body and Pyloric antrum. These parts are existing in mouse as Forestomach, Corpus
and Antrum respectively [87], [88]. The epithelial lining of the corpus and antrum are
buildup of long tubular gastric epithelial glands, which consists of different epithelial
cells [89].
The building block of the glandular part is the gastric gland. The corpus gastric
gland has four unique regions named as Pit, Isthmus, Neck and Base, each one of these
regions is consist of dynamic epithelial cells. For instance, in the Pit region, surface
mucus cells which secret mucus are mainly located. The Isthmus region has stem cells
which has the ability to differentiate and give rise to any of the corpus gland cells.
Mucus neck cells which are also mucus secreting cells are located in the Neck region.
Parietal cells which secret hydrochloric acid are well characterized rounded cells
scattered in the Isthmus, Neck and Base region. Zymogenic cells (also known as chief
cells) which secrete pepsinogen, and Enterochromaffin-like cells (ECL) which
produce histamine are located in the Base region [87], [90].

20
The components of the antral gastric gland are surface mucus cells in the Pit
region, deep mucus cells, gastrin producing G cells, somatostatin producing D-cells
and antral stem cells which are located in the Base [91], [92].
All the above mentioned cells originate from the gastric epithelial stem cells
and their distribution vary in the different parts of the stomach [89]. Therefore, the
gastric glands in the corpus and antrum are histologically different as detailed in
(Figure 1.5).
Gastric epithelial homeostasis is maintained by the gastric stem cells. These
cells not only have the ability to differentiate and give rise to any gastric epithelial cell,
but also continuously regenerate and renew the gastric epithelium [89], [93].
Although previous studies linked VDR signaling to Ca2+ activity and cancer
progress, the normal function of VDR in the stomach and how it can be involved in
gastric homeostasis is unrevealed.
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Figure 1.5: Mouse and human stomach anatomy.
The stomach consists of three sections, forestomach/fundus, corpus and antrum. The
corpus and antrum are glandular units buildup of differentiated and undifferentiated
cells (Modified from [94]). the corpus gastric gland is divided into 4 regions, Pit,
Isthmus, Neck and base. while the antral gastric gland is shorter and consist of two
regions; Pit and Gland.
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1.7 Thesis Objectives and Hypothesis
Based on the literature review provided in early sections, the early discovery
of vitamin D was after series of experiments linked to Rickets disease. However, late
studies showed that vitamin D has substantial contribution at several biological
activities.
As the intestine and other tissues in GI tract are expressing VDR, the
expression and the role of this nuclear receptor in gastric epithelium is not well studied.
The goals of my Master Thesis were to identify the normal expression,
distribution and cellular localization of VDR in gastric epithelium of C57BL/6J mice.
Further, to study the expression of the enzymes (CYP2R1, CYP27A1, CYP27B1,
CYP24A1) involved in vitamin D metabolism.
Since gastric epithelial homeostasis is maintained by gastric stem cells
proliferation and differentiation, this thesis aims also to find the role of VDR in this
process. This will be achieved by demonstrating the long term effect of low serum
vitamin D on gastric epithelium VDR expression mice.
As the hypothesis was that VDR is involved in maintaining gastric epithelial
cell proliferation and differentiation, Immunohistochemistry, RT-PCR and Real-Time
PCR techniques were applied to support it.
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Chapter 2: Methods
2.1 Animals
This study was approved by the Ethics committee of the United Arab Emirates
University (UAEU). C57BL/6J mice were hosted in Specific Pathogen Free (SPF)
environment at the animal facility of Faculty of Medicine and Health Sciences of
UAEU.
After weaning at 3 weeks old, the mice were divided to 3 groups based on the
diet and light exposure as the following:

Table 2.1: Diets and light/dark conditions
Group No.

Diet

Light Cycle

Group 1:

Standard diet:

12 hr light/dark

(SDL)

Standard AIN-93G Rodent Diet with
1000 IU VD3
(D10012Gi, Research Diet)

Group 2:

Standard diet:

(SDD)

Standard AIN-93G Rodent Diet with

No overhead light

1000 IU VD3
(D10012Gi, Research Diet)
Group 3:

VD3 deficient diet:

(VDD)

AIN-93G Growing Rodent Diet with 25
IU VD3/kg of diet
(D17053003i, Research Diet)

No overhead light
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The mice were kept in the previous conditions for 3 months, the weight was
recorded on a weekly basis. The animals were fasted over night before dissection.
Blood was collected for serum analysis and stomach tissue for IHC and Real-Time
PCR.
2.2 Histological Analysis
The collected gastric tissues were fixed by Bouine fixative for 24 hrs, followed
by 70% ethanol and then processed, paraffin embedded and sectioned (5 µm). After
that the sections were deparaffinized and rehydrated for hematoxylin and eosin,
immunoperoxidase staining or immunoflurescent staining. Slides were imaged using
Olympus microscope IX83.
2.2.1 Immunohistochemistry
For immunoperoxidase staining, heat induced antigen retrieval was applied and
then all the sections were pretreated with 3% H2O2 to inhibit endogenous peroxidase
activity. The sections were incubated with 1% Bovine Serum Albumin (blocking
reagent) for 1 hr. Rat polyclonal to anti-VDR antibody (ab115495, abcam, dilution
1:150) was incubated overnight at 4 °C and then biotin-SP conjugated goat anti-rat
IgG (H+L) (112-065-003, Jackson immunoresearch, dilution 1:1000) was used at
room temperature for 1 hr incubation. After PBS wash, sections were incubated with
Extravidin-Peroxidase at dilution 1:1000 in blocking reagent at room temperature
followed by another PBS wash. After that DAB: UREA (1:1) was added to sections
for 6 min then washed twice using distilled water and counterstained with
hematoxylin. The slides were dehydrated prior mountining with DPX.
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Same protocol was follow for peroxidase staining of parietal cells using rabbit
polyclonal to anti-H+K+ATPase-β primary antibody (ab176992, abcam, dilution
1:100) and 2 min incubation with DAB: UREA (1:1).
For 5-bromo-2’-deoxyuridine (BrdU) staining, mice were injected with 120
mg/kg BrdU (B5002, Sigma Aldrich) prepared in sterile distilled water. Intraperitoneal
injection was given 2 hours prior sacrifice. The sections were incubated with mouse
monoclonal to anti-BrdU antibody (MI-11-3, MBL Life Science, dilution 1:500) 1
hour at 4 °C and then followed by 1 hour incubation with biotin-SP conjugated goat
anti-mouse IgG (H+L) (115-065-003, Jackson immunoresearch, dilution 1:500).
2.2.2 Multi-label Immunofluorescence
For co-immunofluorescence staining, PBS wash and permeabilization using
0.1% triton X-100 in PBS were performed after heat induced antigen retrieval. Then
sections were incubated with 1% Bovine Serum Albumin (blocking reagent) for 1 hr
and subsequently incubated overnight at 4 °C with anti-VDR primary antibody raised
in rat (ab115495, abcam, dilution 1:150). Sections were washed with PBS three times
for 5 min and then fluorescent goat anti-rat secondary antibody (112-165-003, Jackson
ImmunoResearch, dilution 1:500) incubated at room temperature for 1 hr were used,
followed by another PBS wash.
Parietal cell marker; rabbit polyclonal to anti-H+K+ATPase-β primary antibody
(ab176992, abcam, dilution 1:100) was incubated along with anti-VDR primary
antibody to detect the expression of VDR in parietal cells. While, lectins UEA-lRhodamine (RL-1062) and GSII (L21415, Life Technologies) were incubated with the
fluorescent goat anti-rat secondary antibody for surface mucus cells and neck mucus
cells detection, respectively. Secondary antibodies used were Cy3-conjugated goat
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anti-rat IgG (H+L) (112-165-003, Jackson ImmunoResearch), Alexa Fluor 448conjugated goat anti-rat IgG (H+L) (112-545-003) and goat anti-rabbit IgG H&L
(TRITC) (ab6718, abcam).
Mounting media with 4′,6-diamidino-2-phenylindole (DAPI) for nuclei
counterstaining was used and finally coverslip was placed. Negative control was
prepared for each experiment by excluding the primary antibodies.
2.3 RNA Isolation
Total RNA was isolated from different parts of the mice stomach (forestomach,
corpus and antrum) using RNeasy Mini Kit (Qiagen). RNA clean-up was performed
using RNase-Free DNase set (Qiagen) as recommended by the manufacturer. To
synthesize cDNA, 1µg of RNA was reverse transcribed using iScript™ cDNA
synthesis kit (Bio-Rad).
2.4 Reverse-Transcription PCR
To study the expression of VDR, CYP2R1, CYP27A1, CYP27B1 and CYP24A1
in normal mouse gastric tissue, Reverse-Transcription PCR was conducted with the
earlier synthesized cDNA using GoTaq Flexi DNA Polymerase kit (Promega) and
using specific primers as detailed in table (2.1).
PCR product was separated by gel electrophoresis method using 2% agarose
gel with Ethidium Bromide and visualized by Gel Doc™ EZ Imager (Bio-rad).
2.5 Quantitative Real-Time PCR
To study fold change in gastric differentiation, proliferation or VDR direct
target genes, quantitative real-time PCR was performed using QuantiStudio ® 5 Real-
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Time PCR instrument (Applied Biosystems (ABI)). SYPER green dye was used for
quantification of dsDNA after every cycle. Specific primers were used as shown in
table (2.2). PCR reaction volumes of 20 µl were used with 40 amplification cycles.
Each sample was tested in triplicate. Gene expression levels were calculated using the
comparative cycle threshold method (ΔΔCT Method) and normalized to GAPDH gene
expression level.
2.6 Serum Analysis for Vitamin D
Blood was collected immediately after sacrifice. Around 1 ml blood samples
were collected in BD vacutainer (Refe. 367957) and centrifuged 3500 rpm for 15 min
at 4°C for serum separation and stored in -80 °C. For Serum 25(OH)D analysis, total
concentration of 25(OH)D (25(OH)D2 + 25(OH)D3) was considered. Liquid
chromatography tandem-mass spectrometry (LC–MS/MS) was used for measuring
25(OH)D2 and 25(OH)D3 concentrations. The LC–MS/MS system was comprised of
a top of the range tandem mass spectrometer, model 8060, in combination with the
Nexera ultra high-pressure liquid chromatography (UHPLC) system (Shimadzu,
Japan).
Prior loading the samples to the LC-MS/MS instrument, extraction step was
performed. Internal standard solution of 25(OH)D3 (6,9,9-D3) was added to the
samples. 1 ml hexane:ethyl acetate (9:1) mixture was used for extraction by adding it
to the sample. The mixture was centrifuged and the organic layer was separated while
the lower layer was further extracted twice by adding hexane:ethyl acetate (9:1)
mixture. Calipratnts and quality controls were processed along the sample. They were
all pooled together and dried at room temperature under sample concentrator. Finally,
methanol/water (75:25, v/v) mixture was used to re-suspend the residue.
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2.7 Gastric Acid Content Measurement
Stomachs collected from the mice on VD3 deficient diet as well as standard
diet were cut along the greater curvature. The stomachs were rinsed with 1 ml 0.9%
NaCl (pH 7.0) and to collect clear supernatant the wash was centrifuged at 5000 rpm
for 10 min. H+ concentration was measured by doing manual titration; the supernatant
against 0.005 M NaOH. The results were normalized to body weight (Kg).
2.8 Statistical Analysis
The statistical analysis was done using Graphpad Prism 7.0.3 to compare the
different groups. The data was analyzed via one-way ANOVA test, Dannett’s multiple
comparisons post-test. Data was expressed as means ± SD. p values < 0.05 were
considered as significant.

Table 2.2: Oligonucleotides primers for VDR, CYPs genes, gastric differentiation markers and some vitamin D3 target genes
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Chapter 3: Results
Earlier studies identified the stomach as target tissue for 1α,25(OH)2D3by
applying indirect method and using radioactive labeled vitamin D [82]. Although this
study is indicating the responsiveness of stomach to vitamin D, the identity of gastric
epithelial cell expressing VDR has not been illustrated yet in normal gastric tissue.
In this study, it was possible to characterize specifically the cells expressing
VDR by following direct method and using specific antibodies for VDR and gastric
epithelial markers. Additionally, it was possible to find out the possible role of VDR
in maintaining gastric epithelial homeostasis by studying vitamin D deficiency by
using vitamin D deficient diet.
3.1 VDR is Expressed in Normal Gastric Epithelial Tissues
To find out the normal distribution of VDR in the stomach parts,
immunolocalization using VDR specific antibody were performed as demonstrated in
(Figure 3.1).
The results showed a positive staining for VDR along the cells of corpus gastric
glands and forestomach of these wild type mice. Nuclear staining as well as
cytoplasmic staining was detected (Figure 3.1- E and F). The negative control showed
no signal of DAP (Figure 3.1- C and D). Interestingly, not only the different parts of
the corpus gastric gland: pit, isthmus, neck and the base were expressing VDR, but
also the muscular part of the gastric tissue. It is worth mention that Stumpf et al
illustrated earlier that cells in the isthmus region are selectively and weakly labeled
with 3H-1,25(OH)2D3 in rat gastric glands [82].
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Furthermore, in agreement with the immunohistochemistry results, RNA
analysis of forestomach, corpus and antrum using PCR and specific VDR primers
confirmed that VDR gene is expressed in these different parts of the stomach (Figure
3.2).
3.2 Cytochrome P450 Genes (CYPs) Involved in VD3 Synthesis and Degradation
are Expressed in the Gastric Epithelial Tissue.
The expression of CYP2R1, CYP27A1 and CYP27B1; Cytochrome P450 genes
(CYPs) involved in VD3 synthesis as well as CYP24A1; another Cytochrome P450
gene involved in breaking down of 1α,25(OH)2D3 had been analyzed in different
regions of the gastric tissue of mouse (Figure 3.3).
RT-PCR detected expression of CYP2R1, CYP27A1 and CYP27B1 genes in
forestomach, corpus and antrum of the wild type mice. Interestingly, expression of
CYP24A1 gene has been detected only in forestomach region of gastric mucosa.
The products size corresponded to the expected sizes of the CYPs genes
amplicons which would have been produced with our primers (Table 2.2).
This great finding suggests that not only the stomach has the ability to
synthesize the 1α,25(OH)2D3, but also it can degrade it when necessary.
3.3 Parietal Cells, Surface Mucous Cells and Mucous Neck Cells Express VDR
Numerous cells in the corpus gastric glands showed VDR expression with
different patterns, nuclear and/or cytoplasmic as showed in (Figure 3.1). In order to
investigate and specify gastric cells expressing VDR, co-immunofluorescence staining
was performed using antibodies and lectins specific for gastric differentiated cells.
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The parietal cells showed co-localization of anti-HK β antibody and anti-VDR
antibody as shown in (Figure 3.4). This co-localization of VDR was nuclear as well as
cytoplasmic. From this finding we can conclude that some parietal cells are expressing
VDR.
Immunostaining of surface mucous cells using UEA lectin showed specific
staining at the pit region of the corpus gastric glands (Figure 3.5-A). Additionally, we
can see in Figure 3.5–B that VDR is expressed along the different cells which building
up the corpus gastric glands. Therefore, to examine whether VDR is expressed in
surface mucous cells dual immunofluorescence staining was performed. The results
showed co-staining of UEA lectin and anti-VDR antibody in this type of cells (Figure
3.5-C), concluding that VDR is expressed in surface mucous cells.
Mucous neck cells were another corpus gastric gland cells that were assessed
for VDR expression. GSll lectin, which specifically stain mucous neck cells in the
gastric mucosa (Figure 3.6-A) as well as anti-VDR antibody (Figure 3.6-B) were
double stained on the same tissue sections.
Immunoreactivity of VDR was detected in mucous neck cells, as there was colocalization of GSII and anti-VDR antibody (Figure 3.6-C).
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Figure 3.1:Immunohistochemical analysis of the corpus gastric glands showing
Vitamin D Receptor (VDR) expression.
Wild type mice (age 2-4 months, n= 3) were sacrificed and stomach was collected.
(A,C,E) The tissues were from forestomach and (B,D,F,G) corpus parts of the stomach
of mouse. (A,B)H&E staining. immunoperoxidase staining using Rat polyclonal to
anti-VDR antibody (dilution1:150, ab115495, abcam) and biotin-SP conjugated goat
anti-rat IgG (H+L) (112-065-003, Jackson immunoresearch) (E,F,G). Scale bar: 200
µm.
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Figure 3.2: VDR mRNA is expressed in the gastric epithelial tissue of C57BL/6J wild
type mouse.
RT-PCR detected expression of VDR gene in gastric epithelial tissue of C57BL/6J wild
type mouse (age 2-4 months, n= 4). The tissues were collected from different parts of
the stomach (Forestomach, Corpus, antrum). The three different parts of the stomach
were expressing VDR gene.

Figure 3.3: Cytochrome P450 genes (CYPs) are expressed in gastric epithelial tissue
of C57BL/6J wild type mouse.
The tissues were collected from gastric epithelial tissue of C57BL/6J wild type mouse
(age 2-4 months, n= 4) different parts of the stomach (Forestomach, Corpus, antrum).
CYP27A1, CYP2R1 and CYP27B1 genes were expressed in the three different part of
the stomach. While CYP24A1 gene was expressed only in forestomach.

Figure 3.4:Parietal cells of corpus gastric glands are expressing VDR.
(C) Co-localization of anti-VDR and anti-HK β primary antibody in parietal cells of corpus gastric glands of C57BL/6J wild type mice (age 2-4
months, n= 3). The histological sections were co-stained with (B) anti-VDR antibody (ab115495, abcam, 1:150 dilution) and (A) anti-HK β primary
antibody (ab176992, abcam, dilution 1:100). Scale bar: 200 µm.
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Figure 3.5: Surface mucous cells of corpus gastric glands are expressing VDR.
(C) Co-localization of anti-VDR and UEA lectin in surface mucous cells of corpus gastric glands of C57BL/6J wild type mice (age 2-4 months,
n= 3). The histological sections were co-stained with (B) anti-VDR antibody (ab115495, abcam, 1:150 dilution) and (A) lectins UEA-l-Rhodamine
(RL-1062). Scale bar: 200 µm.
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Figure 3.6: Mucous neck cells of corpus gastric glands are expressing VDR.
(C) Co-localization of anti-VDR and GSII lectin in mucous neck cells of corpus gastric glands of C57BL/6J wild type mice (age 2-4 months, n=
3). The histological sections were co-stained with (B) anti-VDR antibody (ab115495, abcam, 1:150 dilution) and (A) GSII lectin (L21415, Life
Technologies). Scale bar: 200 µm
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3.4 A Model of Vitamin D Deficient Mouse is Established.
To study the impact of VD3 status on gastric epithelium, and gastric cells
proliferation and differentiation, three groups of mice were fed different diets as
detailed in (Table 2.1).
All diets were well tolerated by the mice. Serum levels of total 25(OH)D
(25(OH)D2 + 25(OH)D3) were used to determine vitamin D status in these three groups
of mice and reported in nanogram/millitre (ng/ml). Holick classification of vitamin D
deficiency in human was followed [95]; vitamin D deficiency defined as 25(OH)D of
<20 ng/ml, vitamin D insufficiency defined as 25(OH)D of 21-29 ng/ml and optimal
level of 25(OH)D is >30 ng/ml.
Serum 25(OH)D analysis for SDL, SDD and VDD groups of mice showed that
low dietary intake of VD3 for 3 months reduced serum 25(OH)D from 33.14 ng/ml in
the control group to 6.81 ng/ml in VDD group. Interestingly, our results demonstrated
that vitamin D insufficiency (24.18 ng/ml) can be generated in mice by providing
normal diet, but eliminating overhead light to prevent endogenous production; detailed
in (Table 3.1).
Moreover, the weight of the mice was measured during the 3 months and
weight gain was observed in VDD group compared to the control, however it was not
dramatic change (p-value >0.05) (Figure 3.7). This finding was consistant with
previous studies which linked vitamin D deficiency and overweight/obesity [96].
Additionally, the mice of the three groups did not suffer from hair loss, and the
physical activity of all the mice was the same, including the mice which had been kept
in dark.
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Table 3.1: The effect of diets containing 1000 IU (standard diet) and 25 UI/Kg VD3
(VD3 deficient diet) on serum 25(OH)D concentration in mice.
Three groups of mice (SDL, SDD, VDD) (age ≈ 4 months) were fed different diet for
a period of 3 months. Blood was collected after sacrifice and total serum 25(OH)D
concentration (25(OH)D2 + 25(OH)D3) was measured. Serum 25(OH)D concentration
was represented as Mean (ng/ml) ± SD. One-way ANOVA test was used for data
analysis. *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001

Group of Mice

N

Mean
(ng/ml)±
SD

Vitamin D Status

P-value

Standard Diet
/Light (SDL)

10

33.14 ± 5.9

Normal vitamin D

NA

Standard Diet
/Dark (SDD)

10

VD3 Deficient Diet
/Dark (VDD)

10

(25(OH)D > 30
ng/ml)

24.18 ± 7.4

vitamin D insufficient
(25(OH)D of 21-29
ng/ml)

6.81 ± 4.5

vitamin D deficient
(25(OH)D of <20
ng/ml)

** P-value
=0.0084

**** P-value
=0.0001
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Mice Weight
30.00

Weight (grams)

25.00

**

20.00

SDL

15.00

SDD
VDD

10.00

5.00

0.00
0
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2

3

4

5

6
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8

9
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Weeks

Figure 3.7: The effect of diets containing 1000 IU VD3 (Standard Diet) and 25 UI/Kg
VD3 (Vitamin D3 Deficient Diet) on mice weight.
Standard Diet /light group (SDL), Standard Diet /Dark group (SDD) and vitamin D
Deficient group of mice (age ≈ 4 months, n= 7/group) were weighted regularly during
12 weeks. Vitamin D deficient mice gained more weight during the 12 weeks period
compared to the control group. However, it wasn’t significant. One-way ANOVA test
was used for data analysis. *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001.
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3.5 Low Vitamin D Status Reduced Gastric Acid Secretion, Relative mRNA
Expression of HKα and HKβ and Increase Gastrin Expression in Mice.
The above results indicated that VDR is highly expressed in normal stomach.
So, it will be necessary to examine the effect of vitamin D deficiency on gastric target
cells (Figure 3.8 and Figure 3.9).
Histological examination of gastric mucosa of the VDD, SDD as well as
control group did not show any noticeable differences among the three groups of mice
in-term of cells morphology, tissue length and overall tissue structure (Figure 3.8-A).
Moreover, parietal cells which are the acid secreting cells in gastric mucosa
were studied. Microscopic examination did not show any morphological changes of
parietal cells (Figure 3.8-B). However, when relative mRNA expression of HKα and
HKβ were measured it was found that mRNA expression of the parietal cell marker
dropped in a significant manner (p-value: 0.0001 and 0.0083 respectively) in vitamin
D deficient group comparing to the control group (Figure 3.9-A-B).
Furthermore, H+ concentration in gastric content collected from stomachs of
fasting mice was measured (Figure 3.9-D). A reduction in H+ concentration was
observed, and consequently lower gastric acid content in vitamin D deficient mice was
detected (p-value: 0.09) suggesting that low levels of serum 25(OH)D may reduce acid
secretion in stomach. It is important to mention that the reduced gastric acid content
in VDD group correlated with the reduced expression of HK subunits (proton pump).
It is well known that parietal cells secretion of acid is regulated by gastrin
hormone [97], so we tested relative mRNA expression of gastrin in the different groups
of mice. Expectedly, the relative expression of gastrin mRNA significantly increased
(P-value: 0.0174) in vitamin D deficient group comparing to the control group. There
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was an increment in gastrin mRNA relative expression in the group of mice kept in
dark, however, this increment was not significant (p-value: 0.27) compared to the
control (Figure 3.9- C).
3.6 Gastric Stem Cells Proliferation Increased in Vitamin D Deficient Mice.
To further understand the relationship between vitamin D status and stem cells
proliferation in gastric mucosa of mice, BrdU staining was performed. BrdU
incorporates with DNA during S phase, detecting newly generated cells.
BrdU labeled proliferating cells were counted by calculating the mean of BrdU
positive cells in the corresponding areas of the gastric mucosa of the different groups
of mice. An increased proliferation in gastric stem cells in the isthmus region of the
corpus gastric gland was observed in vitamin D deficient mice compared to the control
group (p-value: 0.004) (Figure 3.10). From this finding we suggest that low vitamin D
status may increase proliferation rate of normal stem cells in gastric mucosa.
3.7 Expression of VDR, Gastric Differentiation Markers and 1α,25(OH)2D3
Target Genes in Normal and Low Vitamin D Level.
To check the regulatory effect of VD3 on transcription of some genes such as
VDR, gastric differentiation markers and some target genes of 1α,25(OH)2D3 (PTHLH,
p21 and TRPV6) in mouse stomach Real-Time PCR was conducted using RNA
extracted from corpus.
In mice fed diet with low VD3 level, VDR mRNA expression declined (Pvalue: 0.05) compared to the mice in control group (Figure 3.11-A). This result is
expected since VDR expression is associated to endogenous production of
1α,25(OH)2D3 as some studies illustrated [98].
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Figure 3.8: Immunohistochemical analysis of parietal cells showing that size and
morphology didn’t change with low status of 25(OH)D.
(A) H&E staining of gastric mucosa of SDL, SDD and VDD group of mice. (B)
Peroxidase staining of parietal cells of SDL, SDD and VDD group of mice (age ≈ 4
months, n= 4/group) using anti-HKβ primary antibody (ab176992, abcam, dilution
1:100) shows no detection of parietal cells atrophy in vitamin D deficient mice. Scale
bar: 200 µm.
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Figure 3.9: Low serum 25(OH)D concentration reduces HK sub-units gene expression
and gastric acid secretion.
(A-C) Relative mRNA expression of HKα and HKβ significantly decreased, while
expression of gastrin mRNA increased in VDD mice. (D) Gastric acid content
decreased in vitamin D3 deficient mice comparing to the normal mice. (age ≈ 4 months,
n= 7/group). One-way ANOVA test was used for data analysis. *p<0.05, **p<0.01,
***p<0.001, ****p<0.0001.
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B

Figure 3.10: Gastric stem cells proliferation is increased with low serum 25(OH)D
concentration in mice.
(A) Immunohistochemical analysis using anti-BrdU antibody (MI-11-3, MBL Life
Science, dilution 1:500) shows BrdU labeled proliferating cells in isthmus region of
corpus gastric gland of SDL, SDD and VDD groups of mice (age ≈ 4 months, n=
4/gorup). Scale bar: 200 µm. (B) Statistical analysis of BrdU labeled cells illustrate an
increment in number of this cells. One-way ANOVA test was used for data analysis.
*p<0.05, **p<0.01, ***p<0.001, ****p<0.0001.
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Next, we investigated mucus secretion in gastric epithelium in case of low and
normal serum vitamin D level by studying the relative expression of Muc5AC and
Muc6 genes (markers for surface mucus cells and mucus neck cells respectively). Our
results showed a very slight decrease in transcription level of these two genes in
vitamin D deficient mice as well as control dark group compared to the control group
(Figure 3.11-B&C). We suggest that low serum circulating 25(OH)D slightly decrease
the secretory activities of surface mucous cells and mucous neck cells or their
differentiation, and consequently do not impair the gastric mucus secretion.
Moreover, IF gene expression which is another gastric differentiation marker
specific for chief cells, showed a remarkable decline (P-value: 0.0309) in the deficient
group (Figure 3.11-D).
1α,25(OH)2D3 regulates transcription of several genes through VDRE on the
promoter of these target genes. PTHLH, TRPV6 and p21 are VD3 target genes which
are expressed in stomach [44], [52], [48]. When we compared relative mRNA
expression of these genes in gastric mucosa of vitamin D deficient mice and the control
group, we noticed a considerable decrease in PTHLH mRNA relative expression (Pvalue: 0.002), and a slight decrease in TRPV6 and p21 expression (P-value >0.05) in
vitamin D deficient mice (Figure 3.12).
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Figure 3.11: Representative relative mRNA expression of VDR and some gastric
differentiation markers in normal and low serum 25(OH)D concentration in mice.
RNA was extracted from corpus of SDL, SDD and VDD groups of mice (age ≈ 4
months, n= 7/group) and Real-Time PCR was conducted. VDR gene as well as the
differentiation markers expression is decreased in vitamin D deficient mice compared
to the control. One-way ANOVA test was used for data analysis. *p<0.05, **p<0.01,
***p<0.001, ****p<0.0001.
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Figure 3.12: Representative relative mRNA expression of some 1,25(OH)2D3 target
genes in normal and low serum 25(OH)D concentration in mice.
RNA was extracted from corpus of SDL, SDD and VDD groups of mice (age ≈ 4
months, n= 7/group) and Real-Time PCR was conducted. Relative mRNA expression
of PTHLH, TRPV6 and p21 are decreased in vitamin D deficient mice compared to
the control. One-way ANOVA test was used for data analysis. *p<0.05, **p<0.01,
***p<0.001, ****p<0.0001.
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Chapter 4: Discussion
Several studies evaluated the physiological functions of VDR and VD3 status
in humans and rodents. Researchers demonstrated earlier that VD3 is involved in
calcium homeostasis [4], cell differentiation [62] and insulin secretion [78].
VDR is widely distributed in body tissues and organs. In gastrointestinal tract,
small Intestine, colon and gastroesophageal junction are expressing VDR [83], [85].
Additionally, target tissues of 1α,25(OH)2D3 were detected in stomach [82]. The
present study clearly showed expression of VDR in different parts of the gastric
epithelium. Stumph et al demonstrated that only certain cells in rat’s stomach such as
mucous neck cells and chromaffin cells of the gastric glands are considered target cells
of 1α,25(OH)2D3 using radioassay [82]. The results in this thesis showed a wide
distribution of VDR along the corpus gastric glands by using immunohistochemistry
method. Surface mucous cells, neck mucous cells as well as parietal cells exhibited
localization of VDR.
Not only VDR expression was detected, but also CYPs genes which are
involved in 1α,25(OH)2D3 synthesis and breakdown were found expressed in the
different parts of the mouse stomach. We found that the corpus and antrum gastric
glands are specifically expressing CYP2R1, CYP27A1 and CYP27B1, the genes
encoding for the enzymes responsible of producing the 1α,25(OH)2D3 [23], [27], [21],
suggesting that these two parts of gastric epithelium have the ability to locally generate
bioactive VD3.
It was reported earlier that CYP24A1 gene which encodes for the protein that
inactivate 1α,25(OH)2D3 [31] is also regulated by 1α,25(OH)2D3 in negative feedback
loop mechanism through VDRE on the promoter of CYP24A1 [99]. Remarkably, this
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study showed an expression of CYP24A1 gene exclusively in forestomach (Figure 3.3).
This finding indicates a significant role of forestomach in breaking down
1α,25(OH)2D3 when necessary and monitoring local VD3 levels.
The second part of this study focused on investigating the impact of vitamin D
deficiency on gastric epithelial cell differentiation and proliferation as well as gastric
acidity.
It’s well know that the ion pump HK of parietal cells plays a crucial role in
gastric acid secretion by exchanging H+ for K. Moreover acid secretion by parietal
cells is regulated by gastrin hormone [100]. This study reports a decline in gastric
acidity in vitamin D deficient mice along with lower mRNA expression of HKα and
HKβ and increased gastrin mRNA expression. An interesting study carried by Antico
and his team correlated between low serum concentration of 25(OH)D 3 and
Autoimmune

Gastritis

(AIG)

among

Italian

population,

and

suggested

hypovitaminosis D as risk factor for AIG [101]. AIG is caused by auto-production of
antibodies against HK giving rise to inflammation in gastric mucosa, decreased gastric
acid secretion as well as mucosal atrophy at the advanced stages [102].
Furthermore, our results showed a considerable increase in proliferation of
gastric stem cells in vitamin D deficient group compared to the control (P-value: 0.004)
(Figure 3.9). Similarly, other studies illustrated that rats fed VD3 deficient diet for
period of 3 weeks exhibited higher parathyroid cell proliferation compared to rats fed
normal diet [103]. In another study, VDR knockout mice expressed a significant
upregulation in Proliferating Cell Nuclear Antigen (PCNA) in the colon compared to
the wild type mice [104]. Collectively, the results presented in this thesis as well as the
other studies suggest the importance of vitamin D and VDR in regulating cell
proliferation. Moreover, higher gastric stem cells proliferation in vitamin D deficient
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mice might be also linked to higher gastrin expression in this group, since gastrin can
stimulate cell proliferation [105].
By conducting Real-Time PCR, we tested the change in relative mRNA
expression of some gastric differentiation markers such as Muc5AC, Muc6 and IF as
serum concentration of 25(OH)D3 changed in mice. Our results showed down
regulation in all of these differentiation markers as 25(OH)D3 concentration decreased,
however, the change was significant in IF. Concluding that the differentiation of
surface mucous cells, mucous neck cells and chief cells was reduced due to serum
25(OH)D3 concentration reduction. These results were consistent with Driel et al
finding, when he stated that 1α,25(OH)2D3 can induce osteoblast differentiation as he
was investigating the direct effect of 1α,25(OH)2D3 on osteoblast differentiation and
mineralization in human osteoblast cell line (SV-HFO) [106]. In contrast to that, Chen
et al showed an inhibitory role of 1α,25(OH)2D3 treatment on B cells differentiation to
plasma cells. The expression of the key transcription factors involved in plasma cell
differentiation didn’t significantly reduced with 1α,25(OH)2D3 treatment. This finding
suggested that 1α,25(OH)2D3 might have other means to suppress plasma cell
maturation [5].
1α,25(OH)2D3 and VDR can regulate transcription of target genes through
VDRE on their promoter [44]. In the present study, the expression of TRPV6, p21 and
PTHLH have been examined.
TRPV6; Transient Receptor Potential Vanilloid member 6, is Ca2+ channel
which is expressed in stomach and plays role in Ca2+ uptake in GI tract [48], [49].
PTHLH and p21 are another 1α,25(OH)2D3 target genes which are expressed in
stomach. PTHLH is a growth factor regulated by gastrin [107], while p21; CyclinDependent Kinases Inhibitor is a tumor suppressor that cause cell cycle arrest [52].
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The current results showed a slight decline in TRPV6 and p21, while a
significant decrease was reported in PTHLH expression in mice fed VD3 reduced diet
compared to control mice.
Pointing to the impact of low serum 1α,25(OH)2D3 concentration on TRPV6
expression, Walters et al elucidated the positive correlation between duodenum
TRPV6 expression and serum 1α,25(OH)2D3 level in healthy men, regardless of the
age. This finding suggested the effect of low 1α,25(OH)2D3 on intestinal calcium
absorption. However, in healthy women, TRPV6 expression strongly correlated with
age [108]. On the other, Fleet et al reported constant intestinal TRPV6 expression in
mice fed low VD3 diet (25 IU/kg) compared to mice fed normal VD3 diet (1000 IU/kg).
Disclaiming any association between TRPV6 expression level and 1α,25(OH)2D3
concentration [109].
Another target gene is p21, which promotes cell cycle arrest [60]. In vitro study
showed upregulation in p21 and VDR proteins expression in TMK1 cells (Gastric
Adenocarcinoma cell line) when treated with 1α,25(OH)2D3. A reduction in cell
number was observed as well. Suggesting anti-proliferative effect of 1α,25(OH)2D3 in
VDR and p21 dependent manner [110]. In our study, the noticeable upregulation of the
proliferating cells only in vitamin D deficient mice might be related to the
downregulation of p21, even-though this downregulation was not significant.
Mice fed VD3 reduced diet showed considerable downregulation in relative
mRNA expression of PTHLH in corpus tissue, while gastrin mRNA was upregulated.
In contrast to our observations, Al Menhali et at found a regulatory role of gastrin on
PTHLH expression. This regulation was evaluated by increased PTHLH mRNA
abundance after treating wild type mice with gastrin and decreased PTHLH mRNA
expression in gastrin-deficient mice [107]. Therefore, we are suggesting that there
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might be other factors caused reduction in PTHLH expression in VDR and gastrin
independent mechanism in vitamin D deficient mice.
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Chapter 5: Conclusion and Future Directions
The present study aimed to investigate the normal expression, distribution and
cellular localization of VDR in gastric epithelium of C57BL/6 mice. Further, to study
the expression of the enzymes involved in vitamin D metabolism such as CYP2R1,
CYP27A1, CYP27B1 and CYP24A1. Since gastric epithelial homeostasis is
maintained by gastric stem cells proliferation and differentiation, we further aimed to
study the role of VDR and vitamin D3 in such mechanisms. These aims were achieved
by performing different morphological and molecular techniques such as
immunohistochemistry, RT-PCR and Real-Time PCR.
Our results showed i) the expression of VDR both in protein and mRNA levels
in the forestomach, corpus and antrum parts of the gastric epithelium of wild type
C57BL/6 mice, ii) the expression of the enzymes involved in vitamin D metabolism,
and iii) vitamin D deficient mice were expressing lower HKα, HKβ and higher gastrin
mRNA, consequently lower gastric acid content compared to the control mice.
Therefore, it’s very likely that vitamin D deficiency might increase susceptibility of
having gastric disorders related to decreased gastric acidity. Additionally, acceleration
in the proliferation of stem cells in isthmus region of the corpus gastric gland was
observed in vitamin D deficient mice. By investigating the relative mRNA expression
of some gastric differentiation markers such as Muc5AC, Muc6 and IF in low serum
vitamin D status, we found a slight decline in Muc5AC and Muc6 expression and
significant downregulation in IF. To sum up, our study provided data indicating that
vitamin D and VDR are playing a considerable role in maintaining gastric epithelium
differentiation and proliferation.
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These approaches hopefully will improve the awareness regarding relationship
between vitamin D deficiency and gastric diseases such as cancer and minerals
absorption disorders. As we demonstrated a decline in tumor suppressor p21 and
calcium channel TRPV6 mRNA expression in vitamin D deficient mice, we suggest to
provide gastric cancer patients with vitamin D supplements as it has anti-proliferative
effect to restrict tumor progression. Moreover, to prescribe vitamin D supplement to
people suffering from gastric malabsorption of calcium due to vitamin D 3 deficiency.
In the current study, mice were fed VD3 deficient diet for only 3 months, so
this might be a limitation which gave rise to insignificant results in the expression
some differentiation markers and target genes. Thus, to attain more chronic effect of
vitamin D deficiency, extending the diet for period of 6 months to 1 year is
recommended. Considering VD3 deficient diet with high calcium (2%) and high
phosphate (1.25%) (rescue diet) to avoid hypocalcemia and hyperparathyroidism.
Furthermore, changing the mice strain to Nude mice might be an option, to allow more
UV-B radiation penetration to the skin and eliminate hair as barrier in the control
group. Additionally, it was discovered earlier that

activation of VDR through

1α,25(OH)2D3 treatment in mice resulted upregulation in cholesterol 7a-hydroxylase
(CYP7A1) mRNA and reduced level of cholesterol [111]. CYP7A1 is an enzyme
which can metabolize cholesterol to bile acids in liver [112]. So, in future experiments,
cholesterol can be measured in serum as well to study the correlation between
cholesterol and vitamin D deficiency.
Moreover, to further study the mechanism of VD3 and VDR action in
maintaining gastric epithelial homeostasis (genetic or non-genetic), in vitro study can
be conducted by treating mGEP cells with 1α,25(OH)2D3 and VDR antagonist
(ZK159222); a vitamin D3 analogue which has the ability to prevent VDR interaction

56
with the coactivators and consequently inhibit the genetic response [113], [62]. mGEP
cell line; Mouse Gastric Epithelial Progenitor, is transgenic cell line established from
the gastric mucosa of transgenic mouse expressing the simian virus 40 large T antigen
gene in the parietal cell lineage. These cells will be very beneficial in understanding the
possible role of vitamin D on gastric cell differentiation and proliferation [114].

Furthermore, to expand our findings and understand the role of vitamin D in
regulating gastric stem cells proliferation, mGEP cells could be treated with different
doses of 1α,25(OH)2D3 (10-9, 10-8, 10-7 and 10-6 M) and then cell viability test and cell
count could be performed [115].
Moreover, we found in the present thesis that the different parts of the stomach
are expressing the CYPs genes involved in vitamin D metabolism. So, to have better
understanding of how the stomach can regulate 1α,25(OH)2D3 synthesis and
degradation independently from liver and kidney, a further experiment including RealTime PCR is recommended to check the relative mRNA expression change of
CYP2R1, CYP27A1, CYP27B1 and CYP24A1 genes in the control group and VDD
group.
Finally, in Dr. Asma’s lab, we demonstrated the expression of VDR, Estrogen
Receptor (ER) as well as Parathyroid Hormone 1 Receptor (PTH1R) in forestomach
of wild type mice, so more study about this ignored tissue is highly important since
little is known about it.
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Appendix

Supplementary table S.1: Representative table showing the different vitamin D metabolites detected by LC-MS/MS in serum of SDL group of
mice.
S.NO
1
2
3
4
5
6
7
8
9
10
Mean

Sample type volum(uL) 1,25(OH)2-D3
(ng/ml)
SDl2
200
12
SDL3
150
SDL4
250
SDL5
300
SDL7
150
SDL8
150
SDL9
150
8
SDL12
150
7
SDL13
150
SDL14
100
5
0
0
8.00

1,25(OH)2-D2
(ng/ml)
13
10

8.5
6
9
9.30

3-EPI-25OHD3 25OHD-3
(ng/ml)
(ng/ml)
10.4
25
12
22
8
30
3.5
15
16
21
10
19
15
27
8
21
15
6.3
17.5
9.91
21.25

25OHD-2 25OH(D2+D3)
(ng/ml)
(ng/ml)
16
41
6.5
28.5
15
45
10
25
11.4
32.4
15
34
7
34
13
34
10
25
15
32.5
11.89
33.14

7,C4
(ng/ml)
10
26
6
21
19
20
6

VIT D3
(ng/ml)
15
24
32
40
20
6

5
8.5
13.50

30
23.86

VIT D2
(ng/ml)
0
15
14
5
12
45
32
24
20
20.88
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Supplementary table S.2: Representative table showing the different vitamin D metabolites detected by LC-MS/MS in serum of SDD group of
mice.

S.NO
1
2
3
4
5
6
7
8
9
10
Mean

Sample type volum(uL) 1,25(OH)2-D3
(ng/ml)
SDD1
150
9
SDD2
150
SDD5
150
SDD7
50
SDD8
50
SDD9
150
SDD11
150
SDD12
250
SDD13
150
SDD15
150
9.00

1,25(OH)2-D2
(ng/ml)
7
9

10
8.67

3-EPI-25OHD3 25OHD-3
(ng/ml)
(ng/ml)
3.5
9.5
2.5
10
10
16
12
7
14
17
16.5
11
16
6
12
3
20
6.86
13.80

25OHD-2 25OH(D2+D3)
(ng/ml)
(ng/ml)
19
28.5
12
22
8.5
24.5
8.8
15.8
6.5
20.5
21.5
38.5
3.5
20
16
24
36
20
12.98
24.18

7,C4
(ng/ml)
1.51
16
3.5
4
7.5
22

VIT D3
(ng/ml)

VIT D2
(ng/ml)

25

24
40
38

32
5.5
8.57

28.50

21
8
23
32
26.57
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Supplementary table S.3: Representative table showing the different vitamin D metabolites detected by LC-MS/MS in serum of VDD group of
mice.

S.NO
1
2
3
4
5
6
7
8
9
10
Mean

Sample type volum(uL) 1,25(OH)2-D3
(ng/ml)
VDD1
50
VDD2
50
VDD3
50
VDD4
50
VDD5
50
VDD6
50
VDD8
50
VDD9
50
VDD12
50
VDD14
50

3-EPI-25OHD3 25OHD-3
(ng/ml)
(ng/ml)
3.9
1.8
1.3
1.5
18
1.4
3
2.6
0.5
3.6
9
1.50
4.51

25OHD-2 25OH(D2+D3)
(ng/ml)
(ng/ml)
4
7.9
1.7
3.5
1.6
2.9
18
1.3
2.7
3.6
6.6
0.8
3.4
5
5.5
2
5.6
3
12
2.56
6.81

7,C4
(ng/ml)

VIT D3
(ng/ml)

VIT D2
(ng/ml)

8
6

10
7
2
6.75

9

5.1
4
12

9.00

6.78
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